Author(s): Seth P. Lerner, M.D., Catherine Tangen, Dr.P.H., Robert S. Svatek, M.D., Siamak Daneshmand, M.D., Kamal S. Pohar, M.D., Eila Skinner, M.D., Anne Schuckman, M.D., Arthur I. Sagalowsky, M.D., Norm D. Smith, M.D., Ashish M. Kamat, M.D., Wassim Kassouf, M.D., Melissa Plets, M.S., Rick Bangs, M.B.A. https://orcid.org/0000-0002-0706-8775, Theresa M. Koppie, M.D., Ajjai Alva, M.D., Francisco G. La Rosa, M.D., Sumanta K. Pal, M.D., Adam S. Kibel, M.D., Daniel J. Canter, M.D., and Ian M. Thompson, Jr., M.D., for the SWOG S1011 Trial Investigators*
Author Affiliations
From Baylor College of Medicine (S.P.L.) and the University of Texas M.D. Anderson Cancer Center (A.M.K.), Houston, the University of Texas Health San Antonio (R.S.S.) and CHRISTUS Santa Rosa Medical Center Hospital (I.M.T.), San Antonio, and the University of Texas Southwestern Medical Center, Dallas (A.I.S.) — all in Texas; Stanford University, Stanford (E.S.), Norris Comprehensive Cancer Center, University of Southern California, Los Angeles (S.D., A.S.), and City of Hope Medical Center, Duarte (S.K.P.) — all in California; SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Center — both in Seattle (C.T., M.P.); the Ohio State University, Columbus (K.S.P.); the University of Chicago, Chicago (N.D.S.); McGill University Health Center, Montreal (W.K.); the Bladder Cancer Advocacy Network, SWOG Advocates, Pittsford, NY (R.B.); Oregon Health and Science University, Portland (T.M.K.); the University of Michigan, Ann Arbor (A.A.); the University of Colorado, Aurora (F.G.L.R.); Brigham and Women’s Hospital, Boston (A.S.K.); Fox Chase Cancer Center, Philadelphia (D.J.C.); and Oschsner Medical Center, Jefferson, LA (D.J.C.).